180 related articles for article (PubMed ID: 24698192)
1. The Clinical Practice Research Datalink for drug safety in pregnancy research: an overview.
Charlton R; Snowball J; Sammon C; de Vries C
Therapie; 2014; 69(1):83-9. PubMed ID: 24698192
[TBL] [Abstract][Full Text] [Related]
2. Identifying major congenital malformations in the UK General Practice Research Database (GPRD): a study reporting on the sensitivity and added value of photocopied medical records and free text in the GPRD.
Charlton RA; Weil JG; Cunnington MC; de Vries CS
Drug Saf; 2010 Sep; 33(9):741-50. PubMed ID: 20701407
[TBL] [Abstract][Full Text] [Related]
3. Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink.
Naleway AL; Gold R; Kurosky S; Riedlinger K; Henninger ML; Nordin JD; Kharbanda EO; Irving S; Cheetham TC; McCarthy NL
Vaccine; 2013 Jun; 31(27):2898-903. PubMed ID: 23639917
[TBL] [Abstract][Full Text] [Related]
4. Nordic databases to evaluate medications in pregnancy.
Kieler H
Therapie; 2014; 69(1):65-9. PubMed ID: 24698190
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Potential Routine Use of Electronic Healthcare Record Data to Strengthen Early Signal Assessment in UK Medicines Regulation: Proof-of-Concept Study.
Donegan K; Owen R; Bird H; Burch B; Smith A; Tregunno P
Drug Saf; 2018 Sep; 41(9):899-910. PubMed ID: 29725942
[TBL] [Abstract][Full Text] [Related]
6. Development of a mother-child database for drug exposure and adverse event detection in the Military Health System.
Taylor LG; Thelus Jean R; Gordon G; Fram D; Coster T
Pharmacoepidemiol Drug Saf; 2015 May; 24(5):510-7. PubMed ID: 25833769
[TBL] [Abstract][Full Text] [Related]
7. The role of electronic healthcare record databases in paediatric drug safety surveillance: a retrospective cohort study.
de Bie S; Coloma PM; Ferrajolo C; Verhamme KM; Trifirò G; Schuemie MJ; Straus SM; Gini R; Herings R; Mazzaglia G; Picelli G; Ghirardi A; Pedersen L; Stricker BH; van der Lei J; Sturkenboom MC;
Br J Clin Pharmacol; 2015 Aug; 80(2):304-14. PubMed ID: 25683723
[TBL] [Abstract][Full Text] [Related]
8. Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN).
Carbonari DM; Saine ME; Newcomb CW; Blak B; Roy JA; Haynes K; Wood J; Gallagher AM; Bhullar H; Cardillo S; Hennessy S; Strom BL; Lo Re V
Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):999-1003. PubMed ID: 26213344
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of adverse fetal effects of medications (SAFE-Med): findings from the international Clearinghouse of birth defects surveillance and research.
Lisi A; Botto LD; Robert-Gnansia E; Castilla EE; Bakker MK; Bianca S; Cocchi G; de Vigan C; Dutra Mda G; Horacek J; Merlob P; Pierini A; Scarano G; Sipek A; Yamanaka M; Mastroiacovo P
Reprod Toxicol; 2010 Jul; 29(4):433-42. PubMed ID: 20347959
[TBL] [Abstract][Full Text] [Related]
10. [Drug in pregnancy: studies in the French database EFEMERIS].
Damase-Michel C; Lacroix I; Hurault-Delarue C; Beau AB; Montastruc JL;
Therapie; 2014; 69(1):91-100. PubMed ID: 24698193
[TBL] [Abstract][Full Text] [Related]
11. Healthcare databases in Europe for studying medicine use and safety during pregnancy.
Charlton RA; Neville AJ; Jordan S; Pierini A; Damase-Michel C; Klungsøyr K; Andersen AM; Hansen AV; Gini R; Bos JH; Puccini A; Hurault-Delarue C; Brooks CJ; de Jong-van den Berg LT; de Vries CS
Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):586-94. PubMed ID: 24664855
[TBL] [Abstract][Full Text] [Related]
12. Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink.
Kharbanda EO; Vazquez-Benitez G; Shi WX; Lipkind H; Naleway A; Molitor B; Kuckler L; Olsen A; Nordin JD
Am J Obstet Gynecol; 2012 Sep; 207(3 Suppl):S47-51. PubMed ID: 22920059
[TBL] [Abstract][Full Text] [Related]
13. Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens.
Colvin L; Slack-Smith L; Stanley FJ; Bower C
Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1137-50. PubMed ID: 20602344
[TBL] [Abstract][Full Text] [Related]
14. Pediatric post-marketing safety systems in North America: assessment of the current status.
McMahon AW; Wharton GT; Bonnel R; DeCelle M; Swank K; Testoni D; Cope JU; Smith PB; Wu E; Murphy MD
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):785-92. PubMed ID: 26098297
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy exposure registries: academic opportunities and industry responsibility.
Wyszynski DF
Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):93-101. PubMed ID: 19107953
[TBL] [Abstract][Full Text] [Related]
16. Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs.
Lin KJ; Schneeweiss S
Clin Pharmacol Ther; 2016 Aug; 100(2):147-59. PubMed ID: 26916672
[TBL] [Abstract][Full Text] [Related]
17. Determining the predictive value of Read codes to identify congenital cardiac malformations in the UK Clinical Practice Research Datalink.
Hammad TA; Margulis AV; Ding Y; Strazzeri MM; Epperly H
Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1233-8. PubMed ID: 24002995
[TBL] [Abstract][Full Text] [Related]
18. Monitoring outcomes of pregnancy following drug exposure: a company-based pregnancy registry program.
Shields KE; Wiholm BE; Hostelley LS; Striano LF; Arena SR; Sharrar RG
Drug Saf; 2004; 27(6):353-67. PubMed ID: 15144230
[TBL] [Abstract][Full Text] [Related]
19. Creation and evaluation of a multi-layered maternal and child health database for comparative effectiveness research.
Salemi JL; Tanner JP; Bailey M; Mbah AK; Salihu HM
J Registry Manag; 2013; 40(1):14-28. PubMed ID: 23778693
[TBL] [Abstract][Full Text] [Related]
20. Maternal diseases and congenital malformations.
Giardina S; Contarini A; Becca B
Ann Ist Super Sanita; 1993; 29(1):69-76. PubMed ID: 8129274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
